Characterisation of the Timing and Prevalence of Receptor Tyrosine Kinase Expression Changes in Esophageal Carcinogenesis

Anna L Paterson, Maria O'Donovan, Elena Provenzano, Liam J Murray, Helen G Coleman, Brian T Johnson, Damian T McManus, Marco Novelli, Laurence B Lovat, Rebecca C Fitzgerald

Research output: Contribution to journalArticlepeer-review

27 Citations (Scopus)

Abstract

Despite being common in epithelial malignancies, the timing of receptor tyrosine kinase (RTK) up-regulation is poorly understood and therefore hampers the identification of the receptor to target for effective treatment. We aimed to determine if RTK expression changes were early events in carcinogenesis. Esophageal adenocarcinoma and its pre-invasive lesion, Barrett's esophagus, were used for immunohistochemical analysis of the RTK panel, EGFR, ErbB2, ErbB3, Met and FGFR2, by utilising a cohort of patients with invasive disease (n = 367) and two cohorts with pre-invasive disease, one cross-sectional (n = 110) and one longitudinal in time (n = 91). The results demonstrated that 51% of esophageal adenocarcinomas over-expressed at least one of the RTK panel; with 21% of these over-expressing multiple receptors. Up-regulation of RTK expression was an early event corresponding with low grade dysplasia development (25% in areas without dysplasia vs. 63% in low grade dysplasia, p
Original languageEnglish
JournalJournal of Pathology
DOIs
Publication statusPublished - 2012

Fingerprint

Dive into the research topics of 'Characterisation of the Timing and Prevalence of Receptor Tyrosine Kinase Expression Changes in Esophageal Carcinogenesis'. Together they form a unique fingerprint.

Cite this